tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PHAT is currently covered by 4 analysts with an average price target of $25.72. This is a potential upside of $11.66 (82.93%) from yesterday's end of day stock price of $14.06.
Phathom Pharmaceuticals's activity chart (see below) currently has 77 price targets and 74 ratings on display. The stock rating distribution of PHAT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 21.96% with an average time for these price targets to be met of 33.22 days.
Highest price target for PHAT is $28, Lowest price target is $12, average price target is $23.5.
Most recent stock forecast was given by GARY NACHMAN from RAYMOND JAMES on 12-Dec-2025.
Currently out of the existing stock ratings of PHAT, 12 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 17-Feb-2021
$28
$13.94 (99.15%)
$30
1 months 6 days ago
(12-Dec-2025)
0/5 (0%)
$13.43 (92.18%)
Buy
Since 11-Aug-2023
$26
$11.94 (84.92%)
$20
2 months 18 days ago
(31-Oct-2025)
0/9 (0%)
$12.45 (91.88%)
Buy
Since 04-Jan-2023
$28
$13.94 (99.15%)
$28
7 months 12 days ago
(06-Jun-2025)
0/44 (0%)
$19.08 (213.90%)
Buy
Since 01-Mar-2023
$12
$-2.06 (-14.65%)
8 months 16 days ago
(02-May-2025)
2/7 (28.57%)
$9.24 (334.78%)
134
Hold
Since 03-Aug-2022
$12
$-2.06 (-14.65%)
$10
1 years 5 months 9 days ago
(09-Aug-2024)
6/7 (85.71%)
$0.25 (2.13%)
29
What is PHAT (Phathom Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PHAT (Phathom Pharmaceuticals)?
Which analyst is the currently most bullish on PHAT (Phathom Pharmaceuticals)?
Which analyst is the currently most reserved on PHAT (Phathom Pharmaceuticals)?
